Biotech Values

[ghmm]

UTHR:

WOn't have access to call/listen live. Would be curious if they break out response by dose and then of course the next question should be why can't titrate to higher dose? Interollability or just too slow a titration and longer time patients get higher. See it is down $8 pre market it drops enough could be a Biotech Value .

I've been thinking of late an ITMN/UTHR marriage or at least a monogimus relationship makes an awful lot of sense from both perspective (if not obvious can elaborate more later). UTHR has been known to do a deal after a setback too...